Figure 2.

Proportion of person-year (PY) under therapy over the total PY follow up from seroconversion, stratified by time from seroconversion and calendar period, Germany.

Altmann et al. BMC Infectious Diseases 2012 12:94   doi:10.1186/1471-2334-12-94
Download authors' original image